Responding To Market Trends In Prefilled Delivery: A Review Of Component Assessment And Selection
As the industry continues to see significant growth for drug products developed in prefilled syringe (PFS) technologies, there is a trend for pharmaceutical companies to evaluate more complex drug molecules that require delivery systems. The biologics are typically intended for self-administration by the patient and integrate a PFS with an auto-injector to optimize safety, dose accuracy, and ease of use. However, existing plunger technology for PFS was developed for manual injection and does not meet the evolving requirements for drug delivery especially for consistency of injection rate. Download the full paper for more on how West Pharmaceutical is meeting these challenges by automating some or all the parenteral delivery steps.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.